Physician profile
Richard E Benetti
NPI 1174752448
$732.47
in general payments reported to CMS, 2019-2025
15 companies · $31.67 in 2025
The $31.67 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $83.64 · 2021: $18.83 · 2023: $74.14 · 2024: $59.15 · 2025: $31.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $164.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $149.69 | 2019-2024 | Shingrix, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $89.88 | 2019-2025 | Breztri |
| Pfizer INC. | $88.33 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $64.42 | 2019-2020 | |
| Lilly USA, LLC | $63.04 | 2019-2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $55.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.46 | 2019 | |
| Novo Nordisk INC | $31.77 | 2019 | |
| Merck Sharp & Dohme LLC | $26.84 | 2019 | |
| Amgen INC. | $25.53 | 2020 | |
| Novartis Pharmaceuticals Corporation | $22.14 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $21.87 | 2019 | |
| Allergan, INC. | $20.50 | 2019 | |
| Kaleo, INC. | $18.92 | 2019 | |
| Sanofi Pasteur INC. | $16.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Benetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.